Dexamethasone along with ciprofloxacin modulates S. aureus induced microglial inflammation via glucocorticoid (GC)-GC

Rajen Dey1, Biswadev Bishayi1

  • 1Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India.

Insights

Combination therapy with ciprofloxacin and dexamethasone effectively reduced Staphylococcus aureus (S. aureus) induced microglial inflammation and oxidative stress in brain abscesses when the glucocorticoid receptor (GR) was functional. This treatment suppressed inflammatory markers and bacterial burden, conferring host protection.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglial inflammation is central to Staphylococcus aureus (S. aureus) induced brain abscesses.
  • Conventional antibiotics are insufficient for inflammation control, and steroid use in CNS infections is debated.
  • The role of glucocorticoid receptor (GR) in modulating microglial responses to S. aureus is not fully understood.

Purpose of the Study:

  • To investigate the combined effect of dexamethasone and ciprofloxacin on microglial inflammation in S. aureus brain abscesses.
  • To determine the influence of glucocorticoid receptor (GR) status (opened vs. blocked) on the efficacy of this combination therapy.
  • To assess the impact of the treatment on bacterial burden, oxidative stress, cellular functions, and inflammatory markers.

Main Methods:

  • Murine microglia were infected with S. aureus and pre-treated with ciprofloxacin and dexamethasone.
  • Experiments were conducted with GR either open or blocked using the GR antagonist RU486.
  • Assays included cellular motility, intracellular killing, free radical production, antioxidant enzyme activities, corticosterone, cytokine levels, arginase activity, and expression of TLR-2 and GR.

Main Results:

  • The combination treatment significantly reduced bacterial burden and S. aureus-induced oxidative stress only when GR was open.
  • The therapy enhanced SOD and catalase activity, suppressed pro-inflammatory markers at 90 min, and increased arginase activity at 60 and 90 min.
  • Blocking GR with RU486 reversed these beneficial effects, indicating the critical role of the GC-GR pathway.

Conclusions:

  • Combination treatment of ciprofloxacin and dexamethasone effectively regulates S. aureus-induced microglial activation via the GC-GR pathway when GR is functional.
  • This combinatorial approach suppresses inflammation and oxidative stress, offering potential protection against brain abscesses.
  • The findings highlight the importance of GR signaling in mediating the therapeutic effects of combined antibiotic and steroid treatment in CNS infections.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
350
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
383